D. E. Shaw & Co »

Rigel Pharmaceuticals shares owned by D. E. Shaw & Co

Quarter-by-quarter ownership of Rigel Pharmaceuticals (RIGL) shares owned by D. E. Shaw & Co from 13F filings

Historical chart of D. E. Shaw & Co investment in Rigel Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Rigel Pharmaceuticals held by D. E. Shaw & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rigel Pharmaceuticals by D. E. Shaw & Co

Quarter filed Position value Share count Share price at filing
2026-03-31 $12M 446k 27.04
2025-12-31 $18M 424k 42.83
2025-09-30 $8.7M 307k 28.33

More positions owned by D. E. Shaw & Co

NVIDIA Corporation (NVDA)
Microsoft Corporation Put Option (MSFT)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom Call Option (AVGO)
Apple Put Option (AAPL)
Alphabet Cap Stk Cl C Call Option (GOOG)
Micron Technology Put Option (MU)
Meta Platforms Cl A Call Option (META)
Amazon (AMZN)
Boston Scientific Corporation Call Option (BSX)
Advanced Micro Devices Put Option (AMD)
Taiwan Semiconductor Manufac Sponsored Ads Call Option (TSM)
JPMorgan Chase & Co. Call Option (JPM)
Palantir Technologies Cl A Call Option (PLTR)

View all positions for D. E. Shaw & Co

Top funds holding Rigel Pharmaceuticals

BlackRock
Armistice Capital
State Street Corporation
Vanguard Group
Vanguard Capital Management
Acadian Asset Management
Marshall Wace
LSV Asset Management
Renaissance Technologies
D. E. Shaw & Co
Geode Capital Management
Goldman Sachs Group
Arrowstreet Capital, Limited Partnership
Two Sigma Investments
Dimensional Fund Advisors

View all funds holding Rigel Pharmaceuticals